Clinicians often view psoriatic arthritis (PsA) as a rather minor arthritic disorder because
many are unaware of the substantial damage, disability, and reduced quality of life that …

Psoriatic arthritis (PsA) is a form of inflammatory arthritis that occurs in approximately 10% to
30% of individuals with psoriasis, depending on the population studied.(1) Treatment choice …

Psoriatic arthritis is an inflammatory arthritis occurring in up to 30% of patients with psoriasis.
Its clear distinction from rheumatoid arthritis has been described clinically, genetically, and …

Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further
diminishing quality of life, increasing health care costs and cardiovascular risk, and …

Objective: To review the effectiveness of systemic therapies for psoriatic arthritis (PsA).
Methods: Data on the efficacy of PsA therapies from selected literature, including American …

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin
and joint manifestations affecting approximately 2% of the population. In this second of 5 …

In Taiwan, the incidence and prevalence of psoriatic arthritis (PsA) have risen significantly in
recent years. Moreover, data from the Taiwan National Health Insurance Research …

Psoriatic arthritis (PsA) is a chronic, autoimmune, seronegative inflammatory arthritis
characterized by varying degrees of axial and peripheral arthritis. Here, we review the …

Over the past several years, an increased understanding of the pathophysiology of psoriasis
and psoriatic arthritis (PsA) has led to the development of several new biologic therapies …

Psoriatic arthritis (PsA) is a chronic systemic inflammatory disorder characterized by the
association of arthritis and psoriasis. In addition to a heterogeneous and variable clinical …